Fair Value of Financial Instruments - Narrative (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||
|---|---|---|---|---|---|---|---|---|
Nov. 14, 2022 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
Dec. 31, 2019 |
Dec. 31, 2021 |
|
| Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||||
| Reclassifications from other comprehensive loss | $ 100,000 | $ 100,000 | ||||||
| Reclassification adjustment for gain included in net loss | $ 332,000 | $ 0 | 332,000 | $ 0 | ||||
| Equity investments without readily determinable fair value | $ 2,500,000 | $ 2,500,000 | $ 2,500,000 | |||||
| Equity method investments, upward price adjustment | $ 1,500,000 | |||||||
| Subsequent Event | ||||||||
| Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ||||||||
| Proceeds from sale of equity securities | $ 700,000 | |||||||